Target Name: LOC102724192
NCBI ID: G102724192
Review Report on LOC102724192 Target / Biomarker Content of Review Report on LOC102724192 Target / Biomarker
LOC102724192
Other Name(s): Uncharacterized LOC102724192

LOC102724192: A Potential Drug Target and Biomarker

LOC102724192 is a gene that has not yet been characterized, but it is known to encode a protein with potential drug targets and biomarker properties. The protein encoded by this gene is 11 kDa in size and has a predicted localization in the endoplasmic reticulum (ER) and nuclear pore complex (NPC). Based on this information, it is possible that LOC102724192 is involved in the delivery and processing of proteins in the ER and NPC, which could be potential drug targets.

Additionally, LOC102724192 has been shown to interact with several protein tyrosine kinases, including S/T kinase 2 (STK2), which is a known regulator of cell proliferation and survival. This interaction suggests that LOC102724192 may be involved in the regulation of cellular processes, such as cell growth and survival.

Furthermore, LOC102724192 has been shown to have been expressed in a variety of tissues and organs, including brain, heart, liver, and muscle. This suggests that it may be involved in a variety of physiological processes in the body, and could be a potential biomarker for a variety of diseases.

In conclusion, LOC102724192 is a gene that has not yet been fully characterized, but it is known to encode a protein with potential drug target and biomarker properties. Further research is needed to determine the function and role of LOC102724192 in the body.

Protein Name: Uncharacterized LOC102724192

The "LOC102724192 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102724192 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639